The Access to Medicine Index is a very important project. What gets measured, gets done.
New online: the case for fixing the global antibiotic market
This new white paper unpacks why antibiotic supply chains are failing and how this will have a global impact on basic healthcare. It makes the case for fixing the antibiotic market through coordinated action by governments, regulators and industry.
Read more >>
22 Oct 2018
27 Sep 2018
14 Sep 2018
28 Aug 2018
03 Aug 2018
02 Aug 2018
13 Jul 2018
27 Jun 2018
08 Jun 2018
31 May 2018
19 Apr 2018
12 Mar 2018
Interested in working toward the next AMR Benchmark and Access to Medicine Index?
The Foundation is looking for an experienced Research Programme Manager to manage the team developing the AMR Benchmark, two Researchers to join our team, and a Communications Officer who can create and carry out new tactics to strengthen our campaigning approach.
Access to medicine: a material issue for investors
Investors engage with the Foundation for insight into our analysis of the pharma sector, including into governance structures, R&D and pricing strategies.
The foundation on Twitter
“To improve access, we believe pharmaceutical companies need to focus on how
they deploy their products, and, as global citizens, collaborate on the development of strong health systems.”
Jayasree K. Iyer, Executive Director, Access to Medicine Foundation.
The Access to Medicine Foundation and its publications are funded by